Presence & RecognitionEvent: September 4, 2026
Benthic Genomics CEO Solomon Endlich attended a webinar with Cameron Nugent of Sequence Bio to share work on HLA/MHC variation in family-based WGS studies of multiple sclerosis.
Published
Signal category
Presence & Recognition
Quote
“Thank you Cameron Nugent of Sequence Bio for joining Benthic CEO Solomon Endlich this morning and sharing the team’s work on HLA/MHC variation in family-based WGS studies of multiple sclerosis.”
— Benthic Genomics team
Company
Benthic Genomics
Sequencing solutions that reveal the full genomic diversity in humans and other organisms
- Industry
- Biotechnology Research
- Location
- Palo Alto, US
- Company size
- 8 employees
Benthic Genomics, formerly known as Base5 Genomics, converts complex genomic regions into crisp, actionable, and high-confidence genomic calls – at higher precision and scale compared to standard microarray and NGS methods.